Apoptosis regulating proteins as targets of therapy for haematological malignancies

Author： Kornblau S.M. Konopleva M. Andreeff M.

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.8, Iss.12, 1999-12, pp. : 2027-2057

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

IAPs as therapeutic targets in haematological malignancies

By Langemeijer SMC de Graaf AO Jansen JH

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 8, 2008-08 ,pp. : 981-993

Informa Healthcare

Access to resources Recommend Favorite

Monoclonal Antibody Therapy in Haematological Malignancies

Current Clinical Pharmacology, Vol. 5, Iss. 3, 2010-08 ,pp. : 148-159

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in the treatment for haematological malignancies

By Piccaluga Pier Paolo Martinelli Giovanni Baccarani Michele

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 6, 2006-04 ,pp. : 721-732

Informa Healthcare

Access to resources Recommend Favorite

Zinc Homeostasis-regulating Proteins: New Drug Targets for Triggering Cell Fate

Current Drug Targets, Vol. 4, Iss. 4, 2003-05 ,pp. : 323-338

Bentham Science Publishers

Access to resources Recommend Favorite

Antineoplastics: Secondary haematological malignancies following breast cancer therapy: 6 case reports

Reactions Weekly, Vol. 1, Iss. 1083, 2006-01 ,pp. : 6-7

Adis International

Access to resources Recommend Favorite